Trial Details
COMPLETEDBasic Information
| Clinical ID | c1185 |
|---|---|
| Identifier | NCT02589665 |
| Trial Title | A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Mirikizumab|DRUG: Placebo |
Participant Information
| Sponsor | Eli Lilly and Company |
|---|---|
| City | Chula Vista |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2015-12-09 |
|---|---|
| Primary Completion Date | 2017-12-19 |
| Completion Date | 2019-05-07 |